Genetics Meets Business: Precision Medicine with Jessica Gibson
In this episode, we interview Jessica Gibson, CEO and co-founder of Aerial Precision Medicine, about the company's innovative approach to precision medicine. Jessica discusses her journey from studying emergency medicine to leading a company that's using genetics and AI to transform the diagnosis and treatment of chronic diseases. She highlights the importance of addressing the root cause of diseases, the challenges of navigating the healthcare system, and Aerial's work in developing targeted therapies to improve patient outcomes.
Chapters/Timestamps:
- 00:00 - Introduction and Jessica Gibson's Background
- 08:50 - Ariel Precision Medicine and its Mission
- 21:25 - The Role of AI and Technology in Precision Medicine
- 31:54 - Addressing Challenges in Healthcare and Drug Development
- 40:09 - Marketing and Collaboration Strategies
- 47:04 - Jessica Gibson's Vision for the Future of Aerial Precision Medicine
Guest Information:
- Guest's Name: Jessica Gibson
- Guest's Title/Position: CEO and Cofounder
- Guest's Company/Affiliation: Aerial Precision Medicine
- Guest's Bio: Jessica Gibson is the CEO and co-founder of Aerial Precision Medicine. With a background in medicine and science, she transitioned into business and management to drive innovation in healthcare and improve patient outcomes.
Links and Resources:
- Aerial Precision Medicine Website: https://arielmedicine.com/
- Jessica Gibson LinkedIn: https://www.linkedin.com/in/jessica-gibson-80426124
- National Pancreas Foundation: https://nationalpancreasfoundations.org/
- Rebecca's Wish: https://rebeccaswish.org/
- Mission Cure: https://mission-cure.org/
Key Takeaways/Highlights:
- Jessica Gibson's journey from emergency medicine and gastroenterology research to leading Aerial Precision Medicine.
- Aerial Precision Medicine's focus on using genetics and AI to understand the root causes of chronic diseases.
- The challenges of the "diagnostic odyssey" for patients with digestive and metabolic diseases.
- How Aerial Precision Medicine's technology helps to streamline the diagnosis process and personalize treatment plans.
- The importance of data quality and human oversight in the use of AI in healthcare.
- Aerial Precision Medicine's approach to drug development, starting with a deep understanding of the disease.
- The company's emphasis on collaboration with healthcare providers, researchers, and pharmaceutical companies.
- Jessica Gibson's insights on leadership, company growth, and navigating the complexities of the healthcare industry.
Creators and Guests
Host
Heath Fletcher
With over 30 years in creative marketing and visual storytelling, I’ve built a career on turning ideas into impact. From brand transformation to media production, podcast development, and outreach strategies, I craft compelling narratives that don’t just capture attention—they accelerate growth and drive measurable results.
Guest
Jessica Gibson
Jessica Gibson is the CEO and Co-Founder of Ariel Precision Medicine, dedicated to delivering innovative technology to advance the art and science of Precision Medicine. Ariel leverages expert systems to accelerate precision medicine across the healthcare ecosystem by linking diagnostics and patient-centered data, uncovering the mechanisms of disease, and developing targeted treatments—fundamentally transforming patients' lives and outcomes. With a strong record of leadership, Jessica brings creative and solution-oriented problem-solving skills to accomplish strategic goals. At Ariel, she applies a broad range of experience across the pharmaceutical, biotechnology, clinical, and research sectors to develop scalable solutions for some of healthcare's most pressing challenges in chronic disease. Highly driven and grounded in a strong foundation of medical sales and marketing, Jessica is committed to collaborative engagement with diverse stakeholders, always with a patient-focused perspective.